Document is current
Any future updates will be listed below
-
Authors
Stadtmauer, Laurel A.
Schnell, Vicki L.
Park, John K.
Slater, Cristin C.
Foster, Eric D.
Grover, Sarah A.
Heiser, Patrick W.
-
Funding
Funding for this research was provided by:
Ferring Pharmaceuticals, United States
- License Information
-
More Information
Article History
Received: 5 March 2026
Accepted: 22 May 2026
First Online: 29 May 2026
Declarations
:
: L.S., V.S., J.P., and C.S. were investigators in the SARA trial. P.H. and E.F. were employees of Ferring Pharmaceuticals, Inc. during the design, conduct, and analysis of the SARA trial. S.G. is a full-time employee of Ferring Pharmaceuticals A/S.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
